Physician

Internal Medicine

Dr. Mona Saraiya, MD

Mona Saraiya practices Internal Medicine. She went to Rush Medical College. Dr. Mona Saraiya is also published. She has 44 publications published. The lastest publication: "The impact and cost-effectiveness of nonavalent HPV vaccination in the United States: Estimates from a simplified transmission model.'

Publications

The impact and cost-effectiveness of nonavalent HPV vaccination in the United States: Estimates from a simplified transmission model.
Monitoring the impact of human papillomavirus vaccines on high-grade pre-invasive cervical lesions: Designing a framework of linked immunization information system and...
The effectiveness of targeting never or rarely screened women in a national cervical cancer screening program for underserved women.
A door-to-door approach to cervical cancer screening.
Evidence is lacking to support pelvic examinations as a screening tool for non-cervical cancers or other conditions.
Primary care providers human papillomavirus vaccine recommendations for the medically underserved: A pilot study in U.S. Federally Qualified Health Centers.
Demographic Factors Associated with Overuse of Pap Testing.
Women's Clinical Preventive Services in the United States: Who Is Doing What?
Impact of the National Breast and Cervical Cancer Early Detection Program on Cervical Cancer Mortality Among Uninsured Low-Income Women in the U.S., 1991-2007.
Opting Out of Cervical Cancer Screening: Physicians Who Do Not Perform Pap Tests.
Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based population.
Population-based surveillance for cervical cancer precursors in three central cancer registries, United States 2009.
Prevalence of Human Papillomavirus Types in Invasive Cervical Cancers From 7 US Cancer Registries Before Vaccine Introduction.
A need for improved understanding about USPSTF and other evidence-based recommendations.
Overview of the CDC Cervical Cancer (Cx3) Study: An Educational Intervention of HPV Testing for Cervical Cancer Screening.
Evolution of cervical cancer screening and prevention in United States and Canada: implications for public health practitioners and clinicians.
Overuse of Papanicolaou Testing Among Older Women and Among Women Without a Cervix.
Human Papillomavirus Prevalence in Invasive Anal Cancers in the United States Before Vaccine Introduction.
Association of UV Index and Sunscreen Use Among White High School Students in the United States.
Patient knowledge and beliefs as barriers to extending cervical cancer screening intervals in Federally Qualified Health Centers.
Estimates of the timing of reductions in genital warts and high grade cervical intraepithelial neoplasia after onset of human papillomavirus (HPV) vaccination in the U...
Trends in the occurrence of high-grade anal intraepithelial neoplasia in San Francisco: 2000-2009.
Primary care provider practices and beliefs related to cervical cancer screening with the HPV test in Federally Qualified Health Centers.
Factors associated with human papillomavirus vaccination among young adult women in the United States.
Cervical cancer screening among young adult women in the United States.
Annual Report to the Nation on the Status of Cancer, 1975-2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)-Associated Cancers and HPV Vaccination Co...
Cervical cancer screening measures need to evolve to continue to tell the story.
Cervical carcinoma rates among young females in the United States.
Bolivian Health Providers' Attitudes Toward Alternative Technologies for Cervical Cancer Prevention: A Focus on Visual Inspection with Acetic Acid and Cryotherapy.
Do US medical students report more training on evidence-based prevention topics?
Recency of Pap Testing and Future Testing Plans Among Women Aged 18-64: Analysis of the 2007 Health Information National Trends Survey.
Indoor tanning device use among male high school students in the United States.
Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs.
Cancer registries and monitoring the impact of prophylactic human papillomavirus vaccines: the potential role.
Cervical cancer incidence in the United States in the US-Mexico border region, 1998-2003.
Incidence of in situ and invasive vulvar cancer in the US, 1998-2003.
Burden of cervical cancer in the United States, 1998-2003.
Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods.
Human Papillomavirus Prevalence in Invasive Laryngeal Cancer in the United States.
Cervical Cancer-Related Knowledge, Attitudes, and Practices of Health Professionals Working in Brazil's Network of Primary Care Units.
Current cervical cancer screening knowledge, awareness, and practices among u.s. Affiliated pacific island providers: opportunities and challenges.
Human papillomavirus genotype prevalence in invasive penile cancers from a registry-based United States population.
Findings and lessons learned from a multi-partner collaboration to increase cervical cancer prevention efforts in Bolivia.

Schools

Rush University

Doctors Specialties

Preventive Public Health Medicine
Internal Medicine

Accepted Insurances

Education

University of Wisconsin
Rush Medical College

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Paul D. Donnan, MD This Doctor is OpenDoctor Recommended.
	Dr. Lisa B. Bernstein, MD This Doctor is OpenDoctor Recommended.
	Dr. Tarek H. Alansari, MD
	Dr. Abdurahman M. Emsalem, MD This Doctor is OpenDoctor Recommended.
	Dr. Joyce P. Doyle, MD This Doctor is OpenDoctor Recommended.
	Dr. David G. Addiss, MD
	Dr. Sue A. Brenner, MD This Doctor is OpenDoctor Recommended.
	Dr. William D. Flanders II, MD This Doctor is OpenDoctor Recommended.
	Michael M. McNeil, MB